Latest Breaking News On - Biomarker trials - Page 1 : comparemela.com

Is Myocardial Infarction Overdiagnosed?

This Viewpoint examines whether overdiagnosis rather than underdiagnosis may now be the dominant form of myocardial infarction misdiagnosis.

United statesUnited kingdomJamesl januzzi jrAmerican college of cardiologyImbria pharmaceuticalsBoehringer ingelheimEngland comparative effectiveness public affairs councilAbbott laboratoriesNational heartBaim institute for clinical researchWomen heart attack research programBlood institute career development awardCardiology divisionNational institutes of healthUniversal definitionMyocardial infarction

NanoPhoria Bioscience Publishes Groundbreaking Study in Major Cardiology Journal

NanoPhoria Bioscience Publishes Groundbreaking Study in Major Cardiology Journal
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJamesl januzzi jrDaniele catalucciAlessio alognaBiomarker trials baim institute cardiology divisionProfessor of medicine at harvard medical schoolJournal of the american college cardiologyAmerican collegePig modelChronic heart failureDaniele catalucci phdClaudio de lucaHarvard medical schoolHeart failureBiomarker trialsBaim institute

Simple Blood Test May Predict Heart and Kidney Risk in T2D

A baseline assessment of four circulating biomarkers in patients with type 2 diabetes and kidney disease may reveal their future risk for heart and kidney disease progression, a trial analysis reveals.

United statesJamesl januzziJanssen research developmentAmerican diabetes associationAmerican heart association college of cardiologyBaim institute for clinical researchHeart failureBiomarker trialsBaim instituteClinical researchAmerican heartAmerican collegeMedscape medical newsBiomarkers associated with myocardial stressJanssen researchHutter family

Revolutionary diagnostic HART blood tests and platform by Prevencio

Prevencio announced the culminative presentation of patient data demonstrating that its artificial intelligence (AI)-driven HART ® blood tests are highly accurate in a broad range of patients, including those with diabetes, chronic kidney disease, hypertension, obesity, coronary heart disease, heart failure, chronic total occlusion (CTO) of the heart arteries, and Kawasaki disease. The HART platform is disease agnostic and may be used to develop diagnostics beyond

United statesJamesl januzziBaim institute for clinical researchProfessor of medicine at harvard medical schoolIndustry newsMassachusetts general hospitalHarvard medical schoolBiomarker trialsBaim instituteClinical researchPrincipal investigatorRevolutionary diagnostic hart blood tests and platform by prevencio aaccBlood test

Massachusetts General Hospital Researchers and Prevencio Announce the Power of Artificial Intelligence HART® Platform for Medical Diagnostic Test Development

Massachusetts General Hospital Researchers and Prevencio Announce the Power of Artificial Intelligence HART® Platform for Medical Diagnostic Test Development
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

United statesRhonda rhyneJamesl januzziProfessor of medicine at harvard medical schoolInternational spinal cord society scientific sessionsAmerican diabetes association scientific sessionsJournal of american college cardiologyPediatric academic societies international sessionsResearch instituteAnaheim convention center onInternational kawasaki disease symposiumInternational journal of cardiologyJournal of american heart associationBaim institute for clinical researchPrevencio incBlood test company